{"id":105767,"date":"2020-04-19T22:46:47","date_gmt":"2020-04-20T05:46:47","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/crispr-therapeutics-braces-for-severe-impact-from-covid-19-crisis"},"modified":"2020-04-20T09:46:59","modified_gmt":"2020-04-20T16:46:59","slug":"crispr-therapeutics-braces-for-severe-impact-from-covid-19-crisis","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/crispr-therapeutics-braces-for-severe-impact-from-covid-19-crisis","title":{"rendered":"CRISPR Therapeutics braces for \u2018severe impact\u2019 from COVID-19 crisis"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/crispr-therapeutics-braces-for-severe-impact-from-covid-19-crisis2.jpg\"><\/a><\/p>\n<p>April 1, 2020<\/p>\n<hr>\n<p>It was supposed to be an exciting time of next-gen science, where CRISPR gene editing was being used in the first series of human trials in the hope this tech could help cure a range of diseases.<\/p>\n<p>But one of its proponents, CRISPR Therapeutics, has, alongside a growing number of biopharmas, admitted the spreading COVID-19 pandemic is starting to see it be \u201cadversely affected.\u201d<\/p>\n<p>In a <a href=\"http:\/\/archive.fast-edgar.com\/20200331\/AFBIQ22CZC22DJ5E222T2ZZ2SQHDZY22Z222\/crsp-8k_20200331.htm\">Securities and Exchange Commission<\/a> filing Tuesday, the biotech said: \u201cWe are conducting a number of clinical trials for product candidates in the fields of severe hemoglobinopathies and immuno-oncology in geographies which are affected by the coronavirus pandemic.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>April 1, 2020 It was supposed to be an exciting time of next-gen science, where CRISPR gene editing was being used in the first series of human trials in the hope this tech could help cure a range of diseases. But one of its proponents, CRISPR Therapeutics, has, alongside a growing number of biopharmas, admitted [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-105767","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=105767"}],"version-history":[{"count":3,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105767\/revisions"}],"predecessor-version":[{"id":105789,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105767\/revisions\/105789"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=105767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=105767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=105767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}